In this March 31, 2020 file photo, a woman pulls groceries from a cart to her vehicle outside of a Walmart store in Pearl, Miss. Walmart is teaming with the General Motors' Cruise autonomous vehicle unit to test automated package delivery in Arizona. (AP Photo/Julio Cortez, File)
By Michael Balsamo and Ann D'Innocenzio
The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.
The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.
The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.
Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.
“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”
The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.
AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.
The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.
In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.
Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.
The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.
Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.
Updated on December 22, 2020, at 3:44 p.m. ET with additional details.
A report from KPMG International found that global mergers and acquisitions in 2021 reached $5.1 trillion in transactions. Carol Streicher, U.S. deal advisory and strategy service group leader for KPMG, joined Cheddar's "Closing Bell" to talk about the record-breaking year and next year's outlook, which KPMG says could be even more staggering. "We're not seeing any slow down in '22," she said, regarding survey results of 350 business leaders. "Things that were tailwinds for us in M&A activity this past year are going to continue to be tailwinds for us in 2022."
MotorTrend named the Rivian R1T as the 2022 truck of the year - a prestigious title given by the publication as a way for automakers to tout third-party validation. Rivian beat out traditional, legacy truck favorites like Ford and General Motors.
MotorTrend said the company earned high marks for safety, efficiency, value, advanced design, engineering excellence, and performance of intended function. MotorTend head of editorial Ed Loh joins Cheddar News' Closing Bell to discuss.
Stocks closed higher Wednesday on the heels of the Federal Reserve's December meeting. Chairman Jerome Powell announced the central bank would leave interest rates low and unchanged for now, with the anticipation of three hikes next year. The Fed will also speed up the timeline of its asset tapering, beginning in January 2022. Dan Russo, Portfolio Manager and Director of Research at Potomac Fund Management joins Cheddar News' Closing Bell to discuss today's close, how investors reacted to the Fed's announcements, and more.
There is a new way for investors to bet on cannabis - the AdvisorShares Poseidon Dynamic Cannabis ETF targets about 20 of the biggest names in U.S. cannabis. It comes at a time when it's still difficult for investors to access the space. Cheddar News cannabis reporter Chloe Aiello spoke with co-founder and managing director for Poseidon Investment Management, Emily Paxhia.
Victor Li, an economics professor at the Villanova School of Business, joins Cheddar News' Closing Bell, where he discusses the latest Fed decision and the implications it has on the stock market.
Danvas is a new company that aims to bring NFTs and digital artwork into the real world through an interactive, museum-quality display. The company says its product is the first premium, luxury digital art canvas, which it hopes will accelerate the world's appreciation of digital artists and their work, and empower collectors to acquire more NFT art. Danvas also just announced its launch this week, with a $7 million seed round from some big-name backers. Danvas co-founder and CEO Jeanne Anderson joins Cheddar News' Closing Bell to discuss.
The California-based tech company specializing in enterprise cloud-based data analysis of connected internet of things (IoT) has gone public on the NYSE, and Samsara's CFO Dominic Phillips told Cheddar's Kristen Scholer that the timing was right for the public offering for the firm's next phase of growth. "We're going to continue to add to our go-to-market motion, we'll continue to build out our international presence, we'll continue to add more selling capacity specifically as we look to penetrate larger enterprise customers, and we'll look to continue to deploy money in R&D," he said.
Mark Sebastian, CIO of Karman Line Capital, breaks down the Gamestops profitability hurdles and provides an outlook on the company's turnaround strategy.
Actor, pastor, and now author Kel Mitchell joined Cheddar's 'Between Bells' to talk about his new book 'Blessed Mode: 90 Days to Level Up Your Faith' and what inspired him to write it. Mitchell said the book aims to help people boost their physical, mental, and spiritual wellbeing. Ordained as a pastor in 2019, he talked about his service in the church. He also talked about what it was like working with former castmates on Nickelodeon's 'All That' reboot.
